Nu-Med Plus (NUMD) EPS (Diluted) Growth (1y) (2016 - 2025)
Nu-Med Plus (NUMD) EPS (Diluted) Growth (1y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.71 Bn | 194.11 Bn | 7.27 Bn | -47.60% |
| 2 | Stryker | 129.50 Bn | 126.03 Bn | 4.50 Bn | 44.49% |
| 3 | Medtronic | 119.85 Bn | 110.63 Bn | 6.41 Bn | 18.72% |
| 4 | Boston Scientific | 73.79 Bn | 73.25 Bn | 3.85 Bn | 15.24% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | -25.88% |
| 6 | Dexcom | 34.58 Bn | 32.64 Bn | 830.00 Mn | 44.97% |
| 7 | GE HealthCare Technologies | 34.14 Bn | 32.03 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.45 Bn | 23.13 Bn | 4.55 Bn | 71.72% |
| 9 | Steris | 23.23 Bn | 22.74 Bn | 684.20 Mn | 13.96% |
| 10 | Nu-Med Plus | 1.70 Mn | 1.69 Mn | - | 268.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -19.55% |
| Sep 30, 2025 | 37.62% |
| Jun 30, 2025 | 34.30% |
| Mar 31, 2025 | 8.67% |
| Dec 31, 2024 | 81.77% |
| Sep 30, 2024 | -13.84% |
| Jun 30, 2024 | 28.92% |
| Mar 31, 2024 | 24.65% |
| Dec 31, 2023 | -230.03% |
| Sep 30, 2023 | 72.30% |
| Jun 30, 2023 | 59.15% |
| Mar 31, 2023 | 53.88% |
| Dec 31, 2022 | 101.79% |
| Sep 30, 2022 | 51.20% |
| Jun 30, 2022 | 76.06% |
| Mar 31, 2022 | 88.51% |
| Dec 31, 2021 | -219.81% |
| Sep 30, 2021 | 85.03% |
| Jun 30, 2021 | 84.67% |
| Mar 31, 2021 | -94.38% |